Ticker Details
Zevra Therapeutics, Inc.
IPO Date:	April 13, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$592.92M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.18 | 2.46%
Avg Daily Range (30 D):	$0.25 | 2.34%
Avg Daily Range (90 D):	$0.20 | 2.11%

Institutional Daily Volume
Avg Daily Volume:	.18M
Avg Daily Volume (30 D):	1.14M
Avg Daily Volume (90 D):	1M

Trade Size
Avg Trade Size (Sh.):	90
Avg Trade Size (Sh.) (30 D):	80
Avg Trade Size (Sh.) (90 D):	80

Institutional Trades
Total Institutional Trades:	368
Avg Institutional Trade:	$1.22M
Avg Institutional Trade (30 D):	$1.27M
Avg Institutional Trade (90 D):	$1.25M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.21M
Avg Closing Trade (30 D):	$1.01M
Avg Closing Trade (90 D):	$.96M
Avg Closing Volume:	137.39K

News

Mar 18, 2026 @ 10:00 AM XOMA Royalty Reports 2025 Financial Results and Hi... Source: Na

Oct 6, 2025 @ 9:51 PM Zevra Therapeutics Announces Inducement Grants und... Source: Nichol Ochsner

Feb 27, 2025 @ 12:30 PM Zevra Therapeutics Enters Agreement to Sell its Ra... Source: Globe Newswire

Dec 6, 2024 @ 10:00 PM Zevra Therapeutics Announces Organizational Change... Source: N/A

Nov 21, 2024 @ 9:51 PM Zevra Therapeutics Announces U.S. Commercial Avail... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.62	$.2	$1.4
Diluted EPS	$.6	$.19	$1.35
Revenue	$36.22M	$34.13M	$106.47M
Gross Profit
Net Income / Loss	$37.89M	$12.17M	$83.23M
Operating Income / Loss	$52.15M	$9.32M	$-62.94M
Cost of Revenue
Net Cash Flow	$32.96M	$8.29M	$28.59M
PE Ratio

Splits
Dec 28, 2020	1:16